Wegovy vs Mounjaro: The Complete UK Treatment Guide
Is Ozempic the Same as Wegovy? Understanding the Key Differences
The confusion around whether Ozempic is the same as Wegovy stems from both containing identical active ingredient semaglutide. However, this is where the similarities end for UK patients. Ozempic is licensed exclusively for type 2 diabetes management, making any promotion for weight loss illegal off-label advertising under MHRA regulations. Wegovy, by contrast, is specifically licensed for weight management in adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. This fundamental licensing difference means patients seeking prescription-only weight management treatment should focus on comparing Wegovy vs Mounjaro rather than considering Ozempic.
When examining is Ozempic the same as Wegovy from a practical standpoint, the dosing schedules differ significantly despite the shared semaglutide ingredient. Wegovy follows a structured dose escalation from 0.25mg to 2.4mg maintenance dose over 16 weeks, specifically designed for weight management outcomes. The clinical evidence supporting Wegovy comes from the STEP trial programme, demonstrating its efficacy when used alongside a reduced-calorie diet and increased physical activity. Understanding these distinctions helps patients make informed decisions between legitimate weight management options.
Wegovy vs Mounjaro Pricing: Complete UK Cost Comparison
EverydayMeds offers transparent pricing for both Wegovy and Mounjaro, allowing patients to compare costs throughout their treatment journey. Wegovy single pens start at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing through £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and reaching £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout to reach these final prices, whilst returning customers use DOSE25. Our Intro Duo bundle combines the first two doses (0.25mg & 0.5mg) for £169.99, providing convenient treatment initiation.
The question of is Ozempic the same as Wegovy becomes irrelevant when considering legitimate treatment costs, as Ozempic cannot be legally prescribed for weight management in the UK. Mounjaro pricing follows a different structure due to its unique tirzepatide formulation and dosing schedule. Both treatments require identical clinical assessment processes, prescriber review, and cold-chain delivery, ensuring patients receive the same professional service regardless of their chosen prescription-only medicine. Bundle options provide treatment continuity without the inconvenience of multiple orders.
Clinical Evidence: Understanding Wegovy vs Mounjaro Research
The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness in weight management. In STEP 1, patients taking Wegovy alongside diet and exercise experienced approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. STEP 2 demonstrated 9.6% weight reduction in patients with type 2 diabetes, whilst STEP 3 showed 16% loss when combined with intensive behavioural therapy. The SELECT trial revealed a 20% reduction in major cardiovascular events, highlighting broader health benefits beyond weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, evaluating tirzepatide's dual GIP and GLP-1 receptor agonist mechanism. When patients ask is Ozempic the same as Wegovy, the clinical evidence clearly distinguishes these treatments based on their licensed indications and study populations. Both Wegovy and Mounjaro demonstrated efficacy when used as prescription-only medicines alongside lifestyle modifications. However, direct comparison of trial results requires caution due to different study designs, patient populations, and endpoints across the research programmes.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1 produced in the intestines after eating. This mechanism reduces appetite by acting on brain centres controlling food intake, promoting feelings of fullness after smaller meals. The treatment may also reduce food cravings and slow gastric emptying, extending satiety periods between meals. Wegovy's once-weekly injection using the FlexTouch pen device provides consistent therapeutic levels throughout the week. This prescription-only medicine works most effectively when combined with a reduced-calorie diet and increased physical activity, as demonstrated in clinical trials.
EverydayMeds Ordering Process: Assessment to Delivery
Our streamlined process begins with a 3-minute online clinical assessment, gathering essential medical history and current health status information. Qualified prescribers review each application, typically within 3 working days (or 24 hours with express service). Once approved, treatments are dispatched for next-day delivery using specialist cold-chain logistics maintaining the required 2-8°C temperature throughout transit. Patients receive SMS tracking updates and delivery instructions for their prescription-only medicine. Our GPhC-registered pharmacy (#9012878) ensures all treatments meet UK regulatory standards before dispatch.
Storage and Practical Considerations for Treatment Success
Wegovy pens require refrigeration at 2-8°C before first use, but offer significant travel convenience with 6 weeks room temperature storage below 30°C once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for frequent travellers. The FlexTouch pen design provides accurate dose delivery with minimal injection discomfort. Dose escalation follows a mandatory schedule starting at 0.25mg, progressing every 4 weeks to reach the 2.4mg maintenance dose. Patients cannot skip doses during escalation, as this increases the risk of gastrointestinal side effects.
Why Patients Ask: Is Ozempic the Same as Wegovy vs Mounjaro?
The confusion surrounding is Ozempic the same as Wegovy often arises from social media discussions and international information that doesn't apply to UK regulations. Patients researching weight management options encounter references to Ozempic being used "off-label" for weight loss in other countries, creating uncertainty about legal UK options. EverydayMeds clarifies this confusion by offering both licensed weight management treatments: Wegovy (semaglutide) and Mounjaro (tirzepatide). This eliminates the need to consider unlicensed uses of diabetes medications.
The Wegovy vs Mounjaro decision ultimately depends on individual patient factors, tolerability, and prescriber recommendation. Wegovy's established clinical evidence from the STEP programme provides confidence in its weight management efficacy, whilst Mounjaro's dual-hormone mechanism offers an alternative approach. Both prescription-only medicines require identical commitment to lifestyle modifications and long-term treatment adherence. EverydayMeds stocks both options, ensuring patients can access their prescribed treatment without supply interruptions.
Choose Your Weight Management Treatment with Confidence
EverydayMeds eliminates the confusion around is Ozempic the same as Wegovy by providing clear access to both licensed weight management treatments. New customers use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our competitive pricing structure. Our clinical team and prescribers help determine the most appropriate treatment based on individual circumstances, medical history, and treatment goals. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your 3-minute assessment and take the first step towards effective weight management. Both Wegovy and Mounjaro are available with next-day delivery following prescriber approval, ensuring you receive professional support throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
